Xampla is collaborating with Britvic to develop vitamin microcapsules that may be mircopackaged in beverages without affecting the taste and the risk of degradation during transit and storage.
A microscopic droplet of vitamin oil wrapped in a plant-based material protects the vitamin, such as vitamin D, from ultra-violet light, pH imbalance, and pasteurization.
The vitamin microcapsules, according to Xampla, "increase the volume of effective vitamins without affecting the product's taste."
Any oil-based vitamin or flavor, including vitamins A, D, E, and K, can be packaged using this technology.
Simon Hombersley, CEO of Xampla, described their product as microcapsules that “offer an opportunity for big beverage brands to get the vitamins people need directly to them inside everyday products”.
He added that the vitamin microcapsule provides a much-needed, simple solution for brands to infuse vitamin D safely in clear bottles, as well as the potential to micropackage a whole range of other nutrients in the future.
Xampia is working with multi-nationals to bring this product to supermarket shelves.


Bank of Japan Unveils New Inflation Gauge to Support Case for Future Rate Hikes
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Oil Prices Climb as Iran Reviews U.S. Peace Proposal Amid Middle East Tensions
Asian Markets Rally as Oil Prices Tumble and Middle East Peace Hopes Emerge
Citi Names Eric Farina and Rob Cascarino to Lead Global Infrastructure Financing Group
U.S. Praises Kurdistan's Role in Oil Markets Amid Iran War Fallout
Vanda Pharmaceuticals (VNDA) Stock Soars After FDA Approves BYSANTI for Bipolar I and Schizophrenia
Trump Tariffs Show Minimal Economic Impact but Boost Federal Revenue, Study Finds
Innate Pharma Reports 55% Revenue Drop and €49.2M Net Loss for 2025
CK Hutchison's Panama Ports Dispute Escalates as Arbitration Claims Surpass $2 Billion
OpenAI Pulls the Plug on Sora, Ending $1 Billion Disney Partnership
Gold is meant to be a ‘safe haven’ in uncertain times. Why is it crashing amid a war?
WTO Reform Talks Begin in Cameroon Amid Global Trade Tensions
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push 



